Detalles de la búsqueda
1.
A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic.
bioRxiv;
2020 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32637960
2.
A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury.
Cell Rep Med;
1(8): 100137, 2020 11 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33294858
Resultados
1 -
2
de 2
1
Próxima >
>>